Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Graeme J Moyle

Showing results (1-10 of 54) with videos related to

Pageof 6
Sort By:
The AIDS Reader|June 13, 2003
Where now for Trizivir? Role of the triple-NRTI pill post-ACTG 5095Graeme J Moyle
The AIDS Reader|May 6, 2003
Truth, lies, and statistical testsGraeme J Moyle
The AIDS Reader|December 2, 2004
The K65R mutation: selection, frequency, and possible consequencesGraeme J Moyle
Journal of Acquired Immune Deficiency Syndromes (1999)|August 30, 2003
Protease inhibitor-sparing regimens: new evidence strengthens positionGraeme J Moyle
The AIDS Reader|February 13, 2004
Lipid abnormalities during ART: it's the drug, not the classGraeme J Moyle
Current Opinion in Infectious Diseases|April 20, 2002
Fresh starting points for HIV's second centuryGraeme J. Moyle
The AIDS Reader|August 2, 2003
NNRTI choice: has 2NN changed our practice?Graeme J Moyle
The AIDS Reader|December 7, 2005
The role of zidovudine in development of lipoatrophyGraeme J Moyle
The AIDS Reader|November 6, 2003
Boosted PIs: competition hots upGraeme J Moyle
The AIDS Reader|October 2, 2004
Bridging a gap: surgical management of HIV-associated lipoatrophyGraeme J Moyle
Pageof 6

Showing results (1-10 of 54) with videos related to

Sort By:
Pageof 6
The AIDS Reader|June 13, 2003
Where now for Trizivir? Role of the triple-NRTI pill post-ACTG 5095Graeme J Moyle
The AIDS Reader|May 6, 2003
Truth, lies, and statistical testsGraeme J Moyle
The AIDS Reader|December 2, 2004
The K65R mutation: selection, frequency, and possible consequencesGraeme J Moyle
Journal of Acquired Immune Deficiency Syndromes (1999)|August 30, 2003
Protease inhibitor-sparing regimens: new evidence strengthens positionGraeme J Moyle
The AIDS Reader|February 13, 2004
Lipid abnormalities during ART: it's the drug, not the classGraeme J Moyle
Current Opinion in Infectious Diseases|April 20, 2002
Fresh starting points for HIV's second centuryGraeme J. Moyle
The AIDS Reader|August 2, 2003
NNRTI choice: has 2NN changed our practice?Graeme J Moyle
The AIDS Reader|December 7, 2005
The role of zidovudine in development of lipoatrophyGraeme J Moyle
The AIDS Reader|November 6, 2003
Boosted PIs: competition hots upGraeme J Moyle
The AIDS Reader|October 2, 2004
Bridging a gap: surgical management of HIV-associated lipoatrophyGraeme J Moyle
Pageof 6